10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001493152-23-010351`
Period End Date	20221231
Filing Date	20230331
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 40 Cash Flow Statement 76 Stockholders Equity 15

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.09M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$7.14M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$16.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.64M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.68M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$304.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$455.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$36.32M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$195.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.05M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$829.00K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$149.00K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsGross`	$1.97M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsGross`	$1.94M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.08M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.99M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.32M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.20M	USD	Point-in-time
Total assets	`Assets`	$57.70M	USD	Point-in-time
Total assets	`Assets`	$40.49M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$377.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$198.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$438.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$806.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$37.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$178.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$673.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.36M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$659.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$112.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$35.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	-	USD	Point-in-time
Commitments and contingencies (Notes 8, 10, 11, and 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8, 10, 11, and 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, issued and outstanding 696 and 715, respectively	`PreferredStockValue`	$715.00K	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, issued and outstanding 696 and 715, respectively	`PreferredStockValue`	$696.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 48,084,287 and 47,994,672, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 48,084,287 and 47,994,672, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$418.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$417.22M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-380.55M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$61.29M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$56.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$57.70M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$40.49M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$135.00K	USD	Annual
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$141.00K	USD	Annual
Production costs	`ManufacturingCosts`	-	USD	Annual
Production costs	`ManufacturingCosts`	$850.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.99M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$7.67M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$13.07M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$8.67M	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	$1.78M	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	-	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$20.06M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$18.97M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-18.84M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-19.92M	USD	Annual
Loss on investments	`GainLossOnInvestments`	$-1.68M	USD	Annual
Loss on investments	`GainLossOnInvestments`	$-201.00K	USD	Annual
Interest expense and other finance costs	`InterestExpense`	$67.00K	USD	Annual
Interest expense and other finance costs	`InterestExpense`	-	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	-	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$629.00K	USD	Annual
Extinguishment of financing obligation	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Extinguishment of financing obligation	`GainsLossesOnExtinguishmentOfDebt`	$-2.70M	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$216.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$3.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-145.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-2.32M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.49M	USD	Annual
Net Loss	`NetIncomeLoss`	$-19.45M	USD	Annual
Net Loss	`NetIncomeLoss`	$-19.13M	USD	Annual
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	$376.00K	USD	Annual
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	-	USD	Annual
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	Annual
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-329.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.08M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.45M	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.40	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.40	USD	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	48.05M	shares	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	47.34M	shares	Annual

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-19.45M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.13M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$38.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$659.00K	USD	Annual
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-145.00K	USD	Annual
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-35.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	$216.00K	USD	Annual
Extinguishment of financing obligation	`ExtinguishmentOfFinancingObligationAndNotePayables`	-	USD	Annual
Extinguishment of financing obligation	`ExtinguishmentOfFinancingObligationAndNotePayables`	$2.70M	USD	Annual
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$218.00K	USD	Annual
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$116.00K	USD	Annual
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$-680.00K	USD	Annual
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$30.00K	USD	Annual
Impairment of plant property equipment and other assets	`AssetImpairmentCharges`	$1.78M	USD	Annual
Impairment of plant property equipment and other assets	`AssetImpairmentCharges`	-	USD	Annual
Loss (gain) from sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	$-197.00K	USD	Annual
Loss (gain) from sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	$2.32M	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$1.57M	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$954.00K	USD	Annual
Loss on sale of marketable securities	`MarketableSecuritiesGainLoss`	$-1.68M	USD	Annual
Loss on sale of marketable securities	`MarketableSecuritiesGainLoss`	$-47.00K	USD	Annual
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$47.00K	USD	Annual
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-34.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInOtherReceivables`	$551.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInOtherReceivables`	$35.00K	USD	Annual
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$151.00K	USD	Annual
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.63M	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-30.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$688.00K	USD	Annual
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	Annual
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$83.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-185.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$179.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$368.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.96M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.11M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$22.29M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.08M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.72M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$22.54M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$41.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$86.00K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.90M	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$245.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$592.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$185.00K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$10.99M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-631.00K	USD	Annual
Financing obligation payments	`RepaymentsOfLongTermDebt`	$122.00K	USD	Annual
Financing obligation payments	`RepaymentsOfLongTermDebt`	-	USD	Annual
Payoff of financing obligation	`PaymentOfFinancingObligation`	$4.73M	USD	Annual
Payoff of financing obligation	`PaymentOfFinancingObligation`	-	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$80.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$13.04M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.19M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.00K	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.41M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-5.04M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Stock issued to settle accounts payable	`StockIssued1`	$55.00K	USD	Annual
Stock issued to settle accounts payable	`StockIssued1`	-	USD	Annual
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-928.00K	USD	Annual
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-88.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$17.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$19.00K	USD	Annual
Operating Lease - Right of Use Assets	`OperatingLeaserightOfUseAssets`	$18.00K	USD	Annual
Operating Lease - Right of Use Assets	`OperatingLeaserightOfUseAssets`	$680.00K	USD	Annual

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$61.29M	USD	Point-in-time
Balance	`StockholdersEquity`	$56.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$80.00K	USD	Annual
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$13.04M	USD	Annual
Shares issued to pay accounts payable	`SharesIssuedToPayAccountsPayable`	$55.00K	USD	Annual
Series B preferred shares converted to Common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Series B preferred shares converted to Common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.08M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.45M	USD	Annual
Warrant modification	`StockIssuedDuringValueOfWarrantModification`	-	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$954.00K	USD	Annual
Balance	`StockholdersEquity`	$61.29M	USD	Point-in-time
Balance	`StockholdersEquity`	$56.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.